GE HealthCare Technologies GEHC
NASDAQ GEHC
$75.58 +0.96 (+1.29%)
At close: Aug 20, 2026 · 12:13 PM UTC

GE HealthCare Technologies (GEHC) Total Non-Current Liabilities (2022 - 2026)

GE HealthCare Technologies' (GEHC) quarterly Total Non-Current Liabilities came in at $23.9 billion in Q2 2026, up 1.49% YoY from $23.5 billion in Q2 2025, and down 1.31% on a QoQ basis from $24.2 billion in Q1 2026.

GE HealthCare Technologies (GEHC) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

GE HealthCare Technologies (GEHC) has 5 years of Total Non-Current Liabilities data on file, last reported at $23.9 billion in Q2 2026.

  • Quarterly Total Non-Current Liabilities rose 1.49% year-over-year to $23.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.9 billion (up 1.49% YoY) and the FY2025 annual result came in at $24.2 billion, up 7.09% from the prior year.
  • Total Non-Current Liabilities fell to $23.9 billion in Q2 2026, from $24.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $24.2 billion in Q4 2025 to a low of $16.3 billion in Q4 2022.
  • A 5-year average of $22.9 billion and a median of $23.3 billion in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 42.36% — and 2024, when it dropped 4.63%.
  • Tracing GEHC's Total Non-Current Liabilities over 5 years: stood at $16.3 billion in 2022, then surged by 42.36% to $23.3 billion in 2023, then dropped by 2.69% to $22.6 billion in 2024, then grew by 7.09% to $24.2 billion in 2025, then fell by 1.45% to $23.9 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $23.9 billion (Q2 2026), $24.2 billion (Q1 2026), and $24.2 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn -
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn 21.28 Bn
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn 9.07 Bn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn 3.44 Bn
10 Zimmer Biomet Holdings 19.38 Bn 18.97 Bn 1.54 Bn 9.53 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 23.89 Bn
Mar 31, 2026 24.21 Bn
Dec 31, 2025 24.25 Bn
Sep 30, 2025 23.81 Bn
Jun 30, 2025 23.54 Bn
Mar 31, 2025 22.33 Bn
Dec 31, 2024 22.64 Bn
Sep 30, 2024 23.42 Bn
Jun 30, 2024 22.06 Bn
Mar 31, 2024 22.80 Bn
Dec 31, 2023 23.27 Bn
Sep 30, 2023 23.25 Bn
Jun 30, 2023 23.06 Bn
Mar 31, 2023 23.91 Bn
Dec 31, 2022 16.34 Bn